KH
Kuang He
Vice President at Novo Holdings
Copenhagen, Capital Region of Denmark
Overview
Kuang He is a Biotech VC currently serving as Vice President at Novo Holdings, with prior experience at Sofinnova Partners and a background in Biomedical Innovation & Entrepreneurship. He holds a Ph.D. from Indiana University Bloomington and has worked in various roles at esteemed organizations like ExxonMobil and Procter & Gamble.
Highlights of Kuang He's career include serving as a Board Observer at Stealth NewCo and his current position as Vice President at Novo Holdings, where he focuses on investing in digital health, health IT, and other sectors within the biotech industry.
Work Experience
Vice President
2024 - Current
- Focused on company creations in the therapeutics space (pre-Seed, Seed financings) and occasional direct Series A-B investments - Drive strategic decision making in near-clinic and clinical-stage companies in the portfolio
Board Observer
2025
Board Member
2025
Board Observer
2024
Board Observer
2024
Analyst/Associate
2019 - 2023
Focused on equity investments in clinical-stage pharmaceutical and medical devices companies in the CrossOver Fund. Led due diligence on: - Mainstay Medical $108m Series A in 2021 - CytoImmune $27m Series A in 2021 - Artios Pharma $153m Series C in 2021 - Amolyt Pharma $138m Series C in 2023 (acquired by AstraZeneca for $1.05b in 2024)
Clinical Research Fellow - Hematology/Oncology
2017 - 2019
Microbiologist
2014 - 2016
Summer Intern - Beauty & Grooming
2011 - 2011
Noxell Corporation manufactures and markets perfumes, colognes, cosmetic, and toiletry products under CoverGirl brand name.